BTX Quote, Trading Chart, BioTime Inc.
$9.01 Last:
-6.34% Change Percent:
$9.59 Open:
$9.01 Previous Close:
$9.6 High:
$8.7 Low:
880,740 Volume:
10/22/2021 04:57:58 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
BTX Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-10-22 | 9.59 | 9.01 | 9.6 | 8.7 | 880,740 |
| 2021-10-21 | 9.76 | 9.62 | 10.1 | 9.6 | 441,734 |
| 2021-10-20 | 9.47 | 9.73 | 9.75 | 9.16 | 439,424 |
| 2021-10-19 | 9.25 | 9.38 | 9.59 | 9.1742 | 304,121 |
| 2021-10-18 | 9.09 | 9.29 | 9.34 | 9.0306 | 266,223 |
| 2021-10-15 | 9.45 | 9.15 | 9.45 | 9.04 | 418,401 |
| 2021-10-14 | 9.29 | 9.12 | 9.4699 | 9.08 | 277,607 |
| 2021-10-13 | 9 | 9.23 | 9.29 | 8.82 | 468,248 |
| 2021-10-12 | 8.44 | 9.06 | 9.085 | 8.44 | 944,961 |
| 2021-10-11 | 8.29 | 8.5 | 8.67 | 8.25 | 536,101 |
| 2021-10-08 | 8.9 | 8.32 | 8.99 | 8.25 | 710,585 |
| 2021-10-07 | 8.67 | 8.67 | 9.47 | 8.5801 | 830,268 |
| 2021-10-06 | 9.16 | 8.64 | 9.2399 | 8.49 | 577,568 |
| 2021-10-05 | 9.03 | 9.01 | 9.18 | 8.91 | 393,242 |
| 2021-10-04 | 9.06 | 8.99 | 9.2598 | 8.86 | 390,012 |
| 2021-10-01 | 9.29 | 9.14 | 9.3469 | 8.95 | 365,664 |
| 2021-09-30 | 9.05 | 9.3 | 9.67 | 8.95 | 689,024 |
| 2021-09-29 | 9.59 | 9.14 | 9.59 | 9.08 | 408,049 |
| 2021-09-28 | 9.29 | 9.36 | 9.61 | 9.24 | 456,036 |
| 2021-09-27 | 9.43 | 9.52 | 9.87 | 9.42 | 599,259 |
News, Short Squeeze, Breakout and More Instantly...
-
SAN DIEGO, April 21, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc . (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have on the immune system for treating patients with canc...
-
SAN DIEGO, April 15, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc . (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have in treating patients with cancer, blood disorders, a...
-
NEW YORK, March 09, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and mon...